Clinical trial
The Effect of Tecfidera® (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events.
NCT02471560 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Tecfidera® (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events.
- Lead sponsor
- Biogen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 6, 2015
- Completion date
- June 12, 2017
- Enrollment
- 36 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.